Stryker has completed the previously announced acquisition of Inari Medical for a total equity value of nearly $4.9bn, marking a significant expansion into the venous thromboembolism (VTE ...

In January 2025, Stryker entered a definitive agreement to acquire all issued and outstanding shares of Inari Medical’s common stock. Credit: JHVEPhoto / Shutterstock. Stryker has completed the ...

Hiro Murai is one of the most exciting TV directors working today. Now he’s launching his own production to support and discover other visionary artists like himself. Today, Murai announced Chum ...

Stryker completed its acquisition of Inari Medical, the devicemaker said Feb. 19. The companies entered into a definitive agreement for the $4.9 billion acquisition in January. The deal will support ...

In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze surrounding ...

Despite the ongoing craze surrounding the GLP-1 obesity drugs, the healthcare sector was a lagger last year. On January 3, Jared Holz, Mizuho Securities America’s healthcare sector strategist ...

February 19, 2025—Stryker announced that it has completed the acquisition of Inari Medical, Inc., a provider of solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.

Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: ...

So said a stream of octopus enthusiasts, who extolled the many astonishing traits of the beloved, eight-legged cephalopod to a committee of the Oregon Legislature earlier this month. Nearly 70 ...

智通财经APP获悉，国泰君安发布研报称，从开门红表现看白酒需求仍较弱、节后总体平稳，近期股价走势已基本反应市场悲观预期，伴随政策预期回暖白酒板块有望迎来一轮估值修复，建议增持：1)动销较好龙头山西汾酒(600809.SH)、迎驾贡酒(603198.SH)等;2)相对稳健 ...